Fauna Bio

Fauna Bio is an AI-driven drug discovery company that leverages data from 100 million years of evolved disease resistance in mammals to develop novel therapeutic approaches. They utilize a proprietary platform called Convergence™ that identifies and enriches human druggable targets across a wide range of disease areas. Their research focuses on studying extreme animal models, like hibernating mammals, and their resistance to various diseases, including obesity, heart failure, and kidney disease. By understanding the genetic mechanisms behind these natural defenses, Fauna Bio aims to create new drugs that mimic these protective mechanisms for humans.

Fauna Bio has made significant strides in their research, partnering with companies like Eli Lilly for drug discovery in obesity and collaborating with the Zoonomia Consortium, which produced a whole-genome alignment of 240 mammals. They are also actively involved in space-focused research programs, studying the potential protective mechanisms of torpor for space health and examining whether hibernation protects against radiation. With their innovative approach and deep understanding of evolutionary biology, Fauna Bio is at the forefront of developing groundbreaking therapies for a range of diseases.

Fauna Bio is an AI-driven drug discovery company dedicated to advancing human health by leveraging the extraordinary resilience of extreme mammals. Their approach centers on studying the genetic mechanisms underlying disease resistance in animals, particularly those that exhibit remarkable adaptations like hibernation, regeneration, and tolerance to extreme environments. By combining their proprietary biobank of genetic data with their in-house Convergence™ AI platform, Fauna Bio identifies and enriches human druggable targets across a wide range of disease areas, ultimately aiming to develop novel therapies for human diseases.

Fauna Bio fosters a culture that is both innovative and collaborative, driven by a shared passion for leveraging evolutionary insights to solve human health challenges. The company attracts a diverse team of experts from various scientific disciplines, encouraging open dialogue and a willingness to challenge conventional approaches. This results in a dynamic work environment where curiosity, creativity, and interdisciplinary thinking are highly valued, leading to a culture of continuous learning and discovery.

Fauna Bio is committed to building an equitable organization that reflects the diversity of the human population they serve. They actively seek talent across all backgrounds and identities, aiming to create a diverse and inclusive workforce that strengthens their knowledge and opinions on how to develop better drug therapies. Their efforts extend to building partnerships with researchers studying extreme adaptations in animals, ensuring their approach is grounded in a wide range of perspectives.